Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month,multicentre,follow-up study

Abstract

This study was performed to assess the temporal evolution of damage within lesions and the normal-appearing white matter, measured using frequent magnetization transfer (MT) MRI, in relapsing—remitting multiple sclerosis (RRMS). The relationship of MT ratio (MTR) changes with measures of lesion burden, and the sample sizes needed to demonstrate a treatment effect on MTR metrics in placebo-controlled MS trials were also investigated. Bimonthly brain conventional and MT MRI scans were acquired from 42 patients with RRMS enrolled in the placebo arm of a 14-month, double-blind trial. Longitudinal MRI changes were evaluated using a random effect linear model accounting for repeated measures, and adjusted for centre effects. The Expanded Disability Status Scale (EDSS) score remained stable over the study period. A weak, but not statistically significant, decrease over time was detected for normal-appearing brain tissue (NABT) average MTR (—0.02% per visit; p = 0.14), and MTR peak height (—0.15 per visit; p = 0.17), while average lesion MTR showed a significant decrease over the study period (—0.07% per visit; p = 0.03). At each visit, all MTR variables were significantly correlated with T2 lesion volume (LV) (average coefficients of correlation ranging from —0.54 to —0.28, and p-values from <0.001 to 0.02). At each visit, NABT average MTR was also significantly correlated with T1-hypointense LV (average coefficient of correlation = —0.57, p < 0.001). The estimation of the sample sizes required to demonstrate a reduction of average lesion MTR (the only parameter with a significant decrease over the follow-up) ranged from 101 to 154 patients to detect a treatment effect of 50% in a 1-year trial with a power of 90%. The steady correlation observed between conventional and MT MRI measures over time supports the hypothesis of axonal degeneration of fibres passing through focal lesions as one of the factors contributing to the overall MS burden.

Keywords

magnetic resonance imaging magnetization transfer multiple sclerosis normal-appearing brain tissue

Get full access to this article

View all access options for this article.

References

Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002; 15: 239-245.

Filippi M. , Agosta F. Magnetization transfer MRI in multiple sclerosis. J Neuroimaging 2007; 17: 22S-26S.

van Waesberghe JH , Kamphorst W. , De Groot JA , et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability . Ann Neurol 1999; 46: 747-754.

Schmierer K. , Scaravilli F. , Altman DR , Barker GJ , Miller DH Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56: 407-415.

Chen JT , Kuhlmann T. , Jansen GH , et al. Canadian MS / BMT Study Group. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion. NeuroImage 2007; 36: 1152-1158.

Chen JT , Collins DL , Atkins HL , Freedman MS , Arnold DL for the Canadian MS/BMT Study Group. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 2008; 63: 254-262.

Filippi M. , Inglese M. , Rovaris M. , et al. Magnetization transfer imaging to monitor the evolution of MS. A 1-year follow-up study. Neurology 2000; 55: 940-946.

Oreja-Gueavara C. , Charil A. , Caputo D. , Cavarretta R. , Sormani MP , Filippi M. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis. Arch Neurol 2006; 63: 736-740.

Khaleeli Z. , Sastre-Garriga J. , Ciccarelli O. , Miller DH , Thompson AJ Magnetization transfer ratio in the normal-appearing white matter predicts progression of disability over one year in early primary progressive MS. J Neurol Neurosurg Psychiatry 2007; 78: 1076-1082.

10.

Santos AC , Narayanan S. , De Stefano N. , et al. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol 2002; 249: 662-668.

11.

Rovaris M. , Agosta F. , Sormani MP , et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003; 126: 2323-2332.

12.

Agosta F. , Rovaris M. , Pagani E. , Sormani MP , Comi G. , Filippi M. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129: 2620-2627.

13.

Inglese M. , van Waesberghe JH , Rovaris M. , et al. The effect of interferon β-1b on quantities derived from MT MRI in secondary progressive MS. Neurology 2003; 60: 853-860.

14.

Filippi M. , Rocca M. , Pagani E. , et al. European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis. Arch Neurol 2004; 61: 1409-1412.

15.

Filippi M. , Dousset V. , McFarland HF , Miller DH , Grossman RI The role of MRI in the diagnosis and monitoring of multiple sclerosis. Consensus report of the ‘‘White Matter Study Group’’ of the International Society for Magnetic Resonance in Medicine. J Magn Reson Imaging 2002; 15: 499-504.

16.

Filippi M. , Wolinsky JS , Comi G for the CORAL Study Group. (2006). Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study. Lancet Neurol 2006; 5: 213-220.

17.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-1452.

18.

Rovaris M. , Filippi M. , Calori G. , et al. Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 1997; 244: 266-270.

19.

Studholme C. , Hill DL , Hawkes DJ Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimisation of voxel similarity measures. Med Phys 1997; 24: 25-35.

20.

Mesaros S. , Rocca MA , Sormani MP , Charil A. , Comi G. , Filippi M. Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS: a large scale, short-term follow-up study. J Neurol 2008; 255: 1378-1383.

21.

Rovaris M. , Comi G. , Rocca MA , et al for the European/ Canadian Glatiramer Acetate Study Group. Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/ Canadian double-blind, placebo-controlled, MRI-monitored trial. Mult Scler 2007; 13: 502-508.

22.

Rocca MA , Agosta F. , Sormani MP , et al. A three-year, multi-parametric MRI study in patients at presentations with CIS. J Neurol 2008; 255: 683-691.

23.

Rovaris M. , Judica E. , Sastre-Garriga J. , et al. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler 2008; 14: 455-464.

24.

Davies GR , Altmann DR , Hadjiprocopis A. , et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormalities in early relapsing-remitting multiple sclerosis . J Neurol 2005; 252: 1037-1044.

25.

Rocca MA , Mastronardo G. , Rodegher M. , Comi G. , Filippi M. Long-term changes of magnetization transfer-derived measures from patients with relapsing- remitting and secondary progressive multiple sclerosis. AJNR Am J Neuroradiol 1999; 20: 821-827.

26.

Rovaris M. , Bozzali M. , Santuccio G. , et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain 2001; 124: 2540-2549.

27.

Ramio-Torrenta L. , Sastre-Garriga J. , Ingle GT , et al. Abnormalities in normal appearing tissue in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry 2006; 77: 40-45.

28.

Cercignani M. , Iannucci G. , Rocca MA , Comi G. , Horsfield M. , Filippi M. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 2000; 54: 1139-1144.

29.

Cercignani M. , Bozzali M. , Iannucci G. , Comi G. , Filippi M. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis . J Neurol Neurosurg Psychiatry 2001; 70: 311-317.

30.

Ge Y. , Grossman RI , Udupa JK , Babb JS , Kolson DL , McGowan JC Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2001; 22: 470-475.

31.

Davies GR , Ramio-Torrenta L. , Hadjiprocopis A. , et al. Evidence for grey matter MTR abnormalities in minimally disabled patients with early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2004; 75: 998-1002.

32.

Traboulsee A. , Dehmeshki J. , Peters KR , et al. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. Mult Scler 2003; 9: 566-573.